AMP Capital Investors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-613,285
| Closed | -$66.2M | – | 199 |
|
|
2021
Q3 | $66.2M | Sell |
613,285
-65,860
| -10% | -$7.53M | 0.36% | 61 |
|
|
2021
Q2 | $76.5M | Sell |
679,145
-75,444
| -10% | -$8.5M | 0.37% | 58 |
|
|
2021
Q1 | $81.6M | Sell |
754,589
-6,953
| -0.9% | -$744K | 0.41% | 47 |
|
|
2020
Q4 | $80.2M | Buy |
761,542
+2,667
| +0.4% | +$256K | 0.43% | 41 |
|
|
2020
Q3 | $65.9M | Sell |
758,875
-14,159
| -2% | -$1.33M | 0.39% | 53 |
|
|
2020
Q2 | $74.5M | Buy |
773,034
+47,597
| +7% | +$4.19M | 0.47% | 37 |
|
|
2020
Q1 | $54.6M | Buy |
725,437
+30,797
| +4% | +$2.62M | 0.4% | 54 |
|
|
2019
Q4 | $61.5M | Buy |
694,640
+63,987
| +10% | +$5.31M | 0.34% | 66 |
|
|
2019
Q3 | $47.2M | Sell |
630,653
-73,088
| -10% | -$5.01M | 0.26% | 93 |
|
|
2019
Q2 | $49.3M | Sell |
703,741
-72,895
| -9% | -$5.73M | 0.27% | 94 |
|
|
2019
Q1 | $62.1M | Buy |
776,636
+15,076
| +2% | +$1.23M | 0.35% | 64 |
|
|
2018
Q4 | $69.4M | Sell |
761,560
-41,356
| -5% | -$3.64M | 0.44% | 52 |
|
|
2018
Q3 | $75.6M | Sell |
802,916
-57,013
| -7% | -$5.41M | 0.41% | 55 |
|
|
2018
Q2 | $79.7M | Buy |
859,929
+42,592
| +5% | +$4.16M | 0.44% | 50 |
|
|
2018
Q1 | $77.1M | Buy |
817,337
+106,547
| +15% | +$11.7M | 0.44% | 52 |
|
|
2017
Q4 | $68.7M | Sell |
710,790
-22,102
| -3% | -$2.08M | 0.37% | 67 |
|
|
2017
Q3 | $65.1M | Buy |
732,892
+71,093
| +11% | +$5.41M | 0.37% | 71 |
|
|
2017
Q2 | $48M | Sell |
661,799
-68,245
| -9% | -$4.59M | 0.28% | 93 |
|
|
2017
Q1 | $47.8M | Buy |
730,044
+80,815
| +12% | +$5.08M | 0.28% | 87 |
|
|
2016
Q4 | $40.7M | Buy |
649,229
+14,571
| +2% | +$889K | 0.25% | 95 |
|
|
2016
Q3 | $39.9M | Buy |
634,658
+84,972
| +15% | +$5.5M | 0.24% | 92 |
|
|
2016
Q2 | $34M | Sell |
549,686
-106,697
| -16% | -$6.5M | 0.23% | 100 |
|
|
2016
Q1 | $37.4M | Sell |
656,383
-13,895
| -2% | -$774K | 0.25% | 94 |
|
|
2015
Q4 | $40.1M | Buy |
670,278
+74,015
| +12% | +$4.26M | 0.27% | 87 |
|
|
2015
Q3 | $31.5M | Sell |
596,263
-98,486
| -14% | -$6.41M | 0.23% | 102 |
|
|
2015
Q2 | $46.7M | Sell |
694,749
-229,174
| -25% | -$15M | 0.3% | 81 |
|
|
2015
Q1 | $53.8M | Buy |
923,923
+76,319
| +9% | +$4.61M | 0.33% | 81 |
|
|
2014
Q4 | $56.2M | Sell |
847,604
-313,348
| -27% | -$19.8M | 0.34% | 73 |
|
|
2014
Q3 | $67.9M | Sell |
1,160,952
-100,127
| -8% | -$5.56M | 0.43% | 57 |
|
|
2014
Q2 | $71.6M | Sell |
1,261,079
-100,049
| -7% | -$5.25M | 0.44% | 53 |
|
|
2014
Q1 | $69.4M | Buy |
1,361,128
+134,155
| +11% | +$6.78M | 0.47% | 48 |
|
|
2013
Q4 | $65M | Buy |
1,226,973
+287,344
| +31% | +$14.1M | 0.46% | 44 |
|
|
2013
Q3 | $41.7M | Sell |
939,629
-152,477
| -14% | -$6.76M | 0.32% | 69 |
|
|
2013
Q2 | $47.1M | Buy |
+1,092,106
| New | +$47.8M | 0.37% | 57 |
|
Other funds holding ABBV
AMP Capital Investors's ABBV Position: Q4 2021 in Review
AMP Capital Investors sold out of AbbVie (ABBV) in Q4 2021, closing a stake of 613,285 shares — an estimated $66.2M sold.
AMP Capital Investors first reported a position in ABBV in Q2 2013 and held it in 34 quarters. The position peaked at $81.6M in Q1 2021. 2,982 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.
- AMP Capital Investors reported no remaining AbbVie position as of Q4 2021 after selling out during the quarter.
- AMP Capital Investors sold 613,285 AbbVie shares in Q4 2021, an estimated $66.2M.
- AMP Capital Investors first reported a position in AbbVie in Q2 2013 and held it in 34 quarters.
- AMP Capital Investors's AbbVie position peaked at $81.6M in Q1 2021.
- 2,982 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.
Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.